| Pre-Conference Activities|
CREATING WIN-WIN SPONSOR, SITE, INVESTIGATOR RELATIONSHIPS
| Building an Effective Relationship Management Structure with Your Sites
Budget is negotiated and the clinical trial agreement is signed. IRB approval is granted, the trial is starting and everything is going as planned: or is it. Despite every effort made by the investigational site and the sponsor there are often unforeseen challenges that... - Jim George, Senior Director, Clinical Program Management, Sanofi Pasteur
Creating True Sponsor-Site Partnerships
Anthropologic studies of clinical trial investigators reveal a desire to create long term and mutually supportive partnerships with research oriented pharmaceutical companies. Today’s current business practices, suggest that a typical site- sponsor relationship is... - Victoria A. Dwyer, Director, Development Operations, Head of CORE Research Sites, Pfizer Global Research & Development
Becoming Sponsor of Choice: How to Improve Sponsor/Investigator Relationship
Review results of a recent site satisfaction survey, discuss how these results are impacting the way we do business, and provide... - Gretchen Goller, Patient Recruitment and Compliance Specialist, sanofi-aventis, U.S., Inc.
- Richard Robinson, Senior Clinical Project Leader, Cardio-Thrombosis, US-CRU, sanofi-aventis, U.S. Inc.
- Jennifer Green, Regional Clinical Research Associate, sanofi-aventis, U.S., Inc.
The Site as the Client
This session will address how investigator budgets impact patient enrollment and retention and how to improve Sponsor/CRO/Site processes to increase productivity, addressing the issues of investigator budgets and how they impact... - Daniel M. Ulrey, President and Chief Executive Officer, MCSI
- Dr. Jeffrey Adelglass, CEO, Research Across America
| | |
|